- Home
- RNW vs NVCR Comparison
RNW vs NVCR Comparison
Compare RNW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | NVCR |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 1.5B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | RNW | NVCR |
|---|---|---|
| Price | $5.49 | $12.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $7.25 | ★ $28.42 |
| AVG Volume (30 Days) | 1.7M | ★ 1.9M |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 413.66 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,382,164,625.00 | $642,269,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | $17.03 | $5.62 |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | ★ 46.76 | 11.17 |
| 52 Week Low | $5.05 | $10.70 |
| 52 Week High | $8.24 | $34.13 |
Technical Indicators
Market Signals| Indicator | RNW | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 19.72 | 53.32 |
| Support Level | $5.05 | $12.30 |
| Resistance Level | $5.69 | $13.94 |
| Average True Range (ATR) | 0.18 | 0.60 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 16.51 | 62.86 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.